A Science and Technology Blog
With at least two months follow-up data likely to be available earliest only by November or December, the guidance essentially shuts the door on vaccine manufacturers making their vaccines available…
Never before have candidate vaccines been developed from scratch, tested on animals and completed early stages of human clinical trials all under six months. This is an acid test for…
Moderna’s candidate mRNA vaccine for novel coronavirus has no safety issues and is able to elicit immune responses in all the 45 participants, the interim Phase-1 results show. Phase-2 trial…
